Medtronic is recalling 22,763 Mahurkar Acute Dual Lumen High Flow Hemodialysis Catheters due to a potential catheter hub defect that may cause leaks across the catheter’s tubes, the FDA announced. During treatment, the leak could result in mixing of the arterial and venous blood, lead to increased recirculation and poor dialysis, or cause the development of blood clots in the blood vessels, the agency said in a statement. There have been two injuries reported related to this issue and no reports of death. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death, it said. Reference Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MDT:
- Orchestra BioMed begins trading on Nasdaq with cash runway into 2026
- Medtronic recommends rejection of below-market mini-tender by TRC Capital
- Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation
- Medtronic price target lowered to $95 from $100 at Mizuho
- Medtronic Stock (NYSE:MDT) at 8-Year Low. Time to Buy?